XOLAIR SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 300MG/2.0ML
Prescription Only
Drug type: Therapeutic
ATC code: R03DX05
Dosage form: INJECTION, SOLUTION
Route of administration: SUBCUTANEOUS
Active ingredient: Omalizumab; Omalizumab
Registrant
NOVARTIS (SINGAPORE) PTE LTD
Approval Date
2024-06-21
Approval Number
SIN17029P
Manufacturer
Novartis Pharma Stein AG
